26 June 2025

ACR EULAR Guidelines osteomyelitis Paediatrics

‘Crucial foundation’: new criteria for paediatric bone disease

26 June 2025

EULAR Gout

Advances in gout management presented at EULAR 2025

26 June 2025

EULAR Pregnancy

Pregnancy risks elevated in autoinflammatory disease

12 June 2025

EULAR Psoriatic Athritis

Early biologic intervention yields lasting benefit in PsA

12 June 2025

EULAR Rheumatology

Aussies to feature at EULAR Congress 2025

20 June 2024

EULAR

EULAR 2024 highlights

30 November 2023

EULAR Management

New guidelines for managing fatigue in rheum patients

15 June 2023

EULAR Rheumatoid Arthritis

Shingrix immunogenicity in RA patients

8 June 2023

EULAR Technology

What can AI do for rheum?

8 June 2023

Anti JAKS Biologics EULAR Rheumatoid Arthritis

JAKis don’t beat TNFis in high-risk patients

8 June 2023

EULAR MTX Pregnancy

MTX is okay for sperm

5 June 2023

EULAR Public Health

Pearls of wisdom from cancer’s PR team

5 June 2023

Anti JAKS EULAR Rheumatoid Arthritis Sjogren Syndrom

Dual JAK1/TYK2 inhibitor outperforms tofacitinib

5 June 2023

EULAR Lupus Psoriatic Athritis

JAKi fallout reaches PsA guidelines

5 June 2023

EULAR Lupus Osteoporosis

Aussie researchers at EULAR

5 June 2023

Anti JAKS EULAR Rheumatoid Arthritis

CV and cancer risks with JAKi: EULAR perspectives